Janux Therapeutics has partnered with Bristol Myers Squibb in a global licensing and collaboration deal to advance a ...

Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences ...

The United States’ official exit from the World Health Organization (WHO) is set to be finalized today, Thursday January 22, ...

Pharmaceutical Executive: What was Daiichi Sankyo's strategy for preparing for the JP Morgan Healthcare Conference? Ken ...

Under the terms of the agreement, Pfizer is expected to pay an upfront total of $30 million in early 2026 to Novavax, while ...

TopGum Industries signed a binding letter of intent to acquire U.S.-based operations manufacturing pharmaceutical products ...

AI can accelerate drug discovery, clinical development, and patient access, but regulatory hurdles remain. Anders Romare, ...

GSK entered into a definitive agreement to acquire RAPT Therapeutics, including RAPT’s long-acting anti-immunoglobulin E (IgE ...

In today's healthcare environment, securing regulatory approval is only the beginning. The real challenge lies in ensuring ...

In today’s Pharmaceutical Executive Daily, GSK moves to strengthen its immunology pipeline with a $2 billion acquisition of ...

A new study suggests that there is no link between Tylenol and autism. More specifically, the research shows that women ...

The alternative is to purchase a fit-for-purpose solution. This approach requires in-depth investigation to ensure that the ...